life-sciences

Anthropic is starting an internal drug discovery program focused on neglected diseases while launching Claude Science, a product designed for pharmaceutical companies. Life sciences head Eric Kauderer-Abrams said the program aims to provide feedback for developing better AI tools for drugmakers.

OpenAI has released GPT-Rosalind, a large language model trained specifically on 50 common biology workflows and major biological databases. Unlike broader science-focused models from competitors, GPT-Rosalind targets specialized biology tasks including pathway analysis, drug target prioritization, and cross-disciplinary research navigation.